An Elmiron class action lawsuit is a civil suit against a drug manufacturer for failing to warn consumers about the potential risks associated with the use of this prescription medication. In order to win this type of case, plaintiffs must prove they have been affected by the drug’s side effects. Proof of injury is typically in the form of medical records. The length of time healthcare providers must keep these records varies by state. Read More – classactionlawyertn.com
How to Know About Elmiron Class Action Lawsuit
Elmiron lawsuits are filed by people who have developed vision problems due to the medication. Some suffer from loss of color vision, night vision problems, or balance issues. In addition, many have been diagnosed with vision-related injuries. Until recently, these patients had no idea that Elmiron was the cause of their problems. However, they may have discovered the connection through advertisements or other sources.
Elmiron was approved by the FDA in 1997, but the company didn’t tell the FDA of the risks associated with the drug. It wasn’t until 2002 that the company disclosed that patients were suffering from serious eye problems after taking the drug. This led to the creation of a drug safety communication (DSC) that warned patients of potential eye problems.
An Elmiron class action lawsuit will proceed to trial in a New Jersey federal court. The plaintiffs will have a chance to settle their claims for as much as $11 million in compensation. The amount of the settlement will depend on the severity of the plaintiffs’ injuries and the duration of the product’s use. A trial date has been set for January 2023.